Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

F13B / Coagulation factor XIII B chain Antikörper

Produkt-Information von F13B / Coagulation factor XIII B chain Antikörper

Immunogen

Recombinant Human F13B / Coagulation factor XIII B chain protein (Catalog#11510-H08H)

Antibody Type Rabbit Polyclonal Antibody ( Antibody Purification Platform )
Ig Type

Rabbit IgG

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

Produced in rabbits immunized with purified, recombinant Human F13B / Coagulation factor XIII B chain (rh F13B / Coagulation factor XIII B chain; Catalog#11510-H08H; P05160; Met 1-Thr 661). Total IgG was purified by Protein A affinity chromatography.

Usage Guide von F13B / Coagulation factor XIII B chain Antikörper

Specificity

Human F13B / Coagulation factor XIII B chain

Western blot This antibody can be used at 1-2 μg/mL with the appropriate secondary reagents to detect Human F13B in WB. Using a DAB detection system, the detection limit for Human F13B is approximately 0.5 ng/lane under non-reducing conditions and 2 ng/lane under reducing conditions.
Direct ELISA This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human F13B. The detection limit for Human F13B is approximately 0.00245 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Verwandte Produkte & Themen von F13B / Coagulation factor XIII B chain Antikörper

Related Areas:

Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Coagulation Factor XIII B chain

Immunology>>Innate Immunity>>Coagulation>>Coagulation Factor XIII B chain

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
Coagulation Factor XIII B chain Human Coagulation factor XIII B chain Protein, Recombinant 11510-H08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human Coagulation Factor XIII B chain WB, ELISA F13B / Coagulation factor XIII B chain Antibody 11510-RP01

Hintergrund von F13B / Coagulation factor XIII B chain Antikörper

Coagulation factor XIII B chain, also known as Fibrin-stabilizing factor B subunit, Protein-glutamine gamma-glutamyltransferase B chain, Transglutaminase B chain and F13B, is a secreted protein which contains 10 Sushi (CCP / SCR) domains. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as a plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. The B chain of factor XIII is not catalytically active, but is thought to stabilize the A subunits and regulate the rate of transglutaminase formation by thrombin. Factor XIII acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. Defects in F13B are the cause of factor XIII subunit B deficiency (FA13BD) which is an autosomal recessive disorder characterized by a life-long bleeding tendency, impaired wound healing and spontaneous abortion in affected women.

References

  1. Bottenus R.E., et al., 1990, Biochemistry 29: 11195-11209.
  2. Hashiguchi T., et al., 1993, Blood 82: 145-150.
  3. Koseki S., et al., 2001, Blood 97: 2667-2672.
  4. Liu T., et al., 2005, J. Proteome Res. 4: 2070-2080.
  5. Chen R., et al., 2009, J. Proteome Res. 8: 651-661.

Sino Biological Inc. liefert F13B / Coagulation factor XIII B chain Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über F13B / Coagulation factor XIII B chain Antikörper lesen Sie bitte: http:www.sinobiological.com/F13B-Coagulation-factor-XIII-B-chain-Antibody-g-9276.html

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post